← Leaderboards
Janet Crane
Johns Hopkins University
$3,964,821
Attributed
$3,964,821
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $648.3K · FY2014–25$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,964,821 · 5
By mechanism
R01$1,776,034 · 1
P01$1,374,754 · 2
K08$650,283 · 1
R03$163,750 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Robert A Wood$78,863,893
- Bruce S Bochner$17,391,451
- Corinne Keet$22,056,351
- Charles W. Flexner$41,000,447
- Xiaobin Wang$26,054,340
Others in their field
Top investigators on “Signal Pathway”
- David Heimbrook · Leidos Biomedical Research, Inc.$191,912,844
- Asrar B. Malik · University Of Illinois At Chicago$75,811,832
- Robert H Tukey · University Of California San Diego$50,504,865
- Meenhard Herlyn · University Of Pennsylvania$50,308,097
- Ian A Wilson · Scripps Research Institute, The$50,300,809
- Richard D Smith · Battelle Pacific Northwest Laboratories$46,192,560
Research focus
Signal PathwayOsteoblastsOsteogenesisAffectBoneCellsMouse ModelSignal TransductionMediatingImpairmentReportingSkeletonPharmaceutical PreparationsNutrientGeneticBasic ScienceTranslational ResearchOsteoporosisBone MarrowFutureIn VitroOsteoclastsSkeletalKnock-Out
Grant awards (17)
Role of glucocorticoid-suppression of preosteoclast PDGF-BB in skeletal angiogenesis$349,443
R01 · FY2025 · AR · contact PI
PTH Attenuation of Spinal Degeneration During Aging PI Janet Crane$257,003
P01 · FY2025 · AG · contact PI
Role of glucocorticoid-suppression of preosteoclast PDGF-BB in skeletal angiogenesis$349,443
R01 · FY2024 · AR · contact PI
PTH Attenuation of Spinal Degeneration During Aging PI Janet Crane$266,232
P01 · FY2024 · AG · contact PI
Role of glucocorticoid-suppression of preosteoclast PDGF-BB in skeletal angiogenesis$360,250
R01 · FY2023 · AR · contact PI
PTH Attenuation of Spinal Degeneration During Aging PI Janet Crane$272,532
P01 · FY2023 · AG · contact PI
Role of glucocorticoid-suppression of preosteoclast PDGF-BB in skeletal angiogenesis$356,648
R01 · FY2022 · AR · contact PI
PTH Attenuation of Spinal Degeneration During Aging PI Janet Crane$290,892
P01 · FY2022 · AG · contact PI
Role of glucocorticoid-suppression of preosteoclast PDGF-BB in skeletal angiogenesis$360,250
R01 · FY2021 · AR · contact PI
PTH Attenuation of Spinal Degeneration During Aging PI Janet Crane$288,095
P01 · FY2021 · AG · contact PI
Angiogenic Potential in Children with Glucocorticoid-Induced Osteoporosis$81,875
R03 · FY2019 · AR · contact PI
Temporal-spatial Regulation of MSCs by IGF-1$129,243
K08 · FY2018 · AR · contact PI
Angiogenic Potential in Children with Glucocorticoid-Induced Osteoporosis$81,875
R03 · FY2018 · AR · contact PI
Temporal-spatial Regulation of MSCs by IGF-1$129,243
K08 · FY2017 · AR · contact PI
Temporal-spatial Regulation of MSCs by IGF-1$129,243
K08 · FY2016 · AR · contact PI
Temporal-spatial Regulation of MSCs by IGF-1$131,277
K08 · FY2015 · AR · contact PI
Temporal-spatial Regulation of MSCs by IGF-1$131,277
K08 · FY2014 · AR · contact PI